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Summary. Gender-dependent peculiarities of certain biochemical, lipid, pro- and antioxidant blood parameters 
in patients with nonalcoholic fatty liver disease
Gender-dependent peculiarities of certain biochemical, lipid, pro- and antioxidant blood parameters in patients with 
nonalcoholic fatty liver disease (NAFLD) were investigated. In male patients aspartateaminotransferase activity was found 
to increase by 45,4% (p = 0,0003), alanineaminotransferase – by 57,0% (p < 0,0001) and gamma-glutamyltransferase twice 
(p < 0,0001) as compared with the appropriate parameters in females. Male patients with NAFLD were characterized by 
signifi cantly lower at 10,6% (p = 0,03) general cholesterol plasma level as compared with females. That was accompanied 
by decreased plasma concentration of cholesterol of high density lipoproteins and low density lipoproteins by 17,7% 
(p = 0,001) and by 15,4% (p = 0,05) respectively, as compared with female patients. No signifi cant differences between 
NAFLD patients of different gender in parameters of pro- and antioxidant systems were found.
Key words: nonalcoholic fatty liver disease, aspartateaminotransferase, alanineaminotransferase, gamma-
glutamyltransferase, cholesterol
Rezumat. Particularitățile de gen a anumitor parametri biochimici, lipidici, pro și antioxidanți a sângelui la 
pacienții cu boli de fi cat gras nealcolizate
Au fost investigate particularitățile de gen a unor anumiți parametri biochimici, lipidici, pro și antioxidanți a sângelui 
la pacienții cu boli de fi cat gras nealcoоlizate (BFGNA). S-a constatat că la pacienții de sex masculin activitatea aspartata-
minotransferazei a crescut cu 45,4 % (p = 0,0003), alaninaminotransferazei – cu 57,0 % (p =< 0,0001) și gamma-glutamil-
transferazei - de două ori (p < 0,0001), în comparație cu parametrii coresponzători la femei. La pacienții de gen masculin 
cu BFGNA se caracterizează cu un nivel general inferior cu 10,6 % (p = 0,03) în comparație cu acești parametri la femei. 
Aceasta era însoțită de scăderea concentrării colesterolului lipoproteinei cu densitate mare și lipoproteinei cu densitate 
scăzută în plasmă cu 17,7 % (p = 0,001) și 15,4 % (p = 0,05), respectiv în comparație cu pacientele. Diferențe esențiale a 
parametrilor sistemelor pro și antioxidante la pacienți cu BFGNA de diferite sexe n-au fost descoperite.
Cuvinte-cheie: boală de fi cat gras nealcoolizat, aspartataminotransferaza, alaninaminotransferaza, gammaglutamil-
transferaza, colesterol
Резюме. Гендерные особенности отдельных биохимических, липидных, про- и антиоксидантных пара-
метров крови у больных неалкогольной жировой болезнью печени
Исследованы гендерные особенности некоторых биохимических, липидных, про- и антиоксидантных пара-
метров крови у больных неалкогольной жировой болезнью печени (НАЖБП). Установлено, что у пациентов муж-
ского пола активность аспартатаминотрансферазы возрастает на 45,4% (р = 0,0003), аланинаминотрансферазы 
– на 57,0% (р < 0,0001) и гамма-глутамилтрансферазы – в два раза (р < 0,0001), по сравнению с соответствую-
щими параметрами у женщин. Мужской пол у пациентов с НАЖБП характеризуется низшим на 10,6% (р = 0,03) 
общим уровнем холестерина в плазме, по сравнению с женским. Это сопровождалось снижением концентрации 
холестерина липопротеинов высокой плотности и липопротеинов низкой плотности в плазме на 17,7% (р = 0,001) 
и на 15,4% (р = 0,05) соответственно, по сравнению с пациентками. Существенных различий параметров про- и 
антиоксидантной систем между пациентами с НАЖБП разного пола не найдено.




Nonalcoholic fatty liver disease (NAFLD) is the 
most common nosology among liver diseases [1]. Its 
prevalence is 20% – 30% of adults in Western Europe 
and North America and 15% of adult population of 
Asia [4]. Increased incidence of NAFLD is observed 
against the background of a growing number of people 
with obesity, metabolic syndrome and diabetes [3]. 
NAFLD is predicted to become a leading indication 
for liver transplantation in the USA over the next 
20 years, surpassing in this respect chronic hepatitis 
associated with hepatitis C virus [8]. In particular, in 
the USA NAFLD is diagnosed in 34% of the adult 
population [5], and in 3-10% of children [9]. Among 
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various nationalities NAFLD more often occurs in 
Latin American population and rarer this disease is 
detected among African Americans [10]. In Z.W. 
Chen et al. investigation, which included more than 
26,000 patients, the signs of NAFLD was found in 
31% males and 16% females [6]. Some authors 
revealed, that male gender is associated with increased 
aminotransferase activity, more frequent development 
of liver fi brosis and higher total mortality among 
NAFLD patients [10]. Considering all of the above, 
an important medical problem is investigation of the 
gender-specifi c peculiarities of NAFLD. 
The objective of the study was to investigate the 
gender-dependent peculiarities of certain biochemical, 
lipid, pro- and antioxidant blood parameters in 
patients with nonalcoholic fatty liver disease.
Materials and methods. The study involved 139 
patients with nonalcoholic fatty liver disease, which 
were divided into two groups according to their 
gender. The fi rst group consisted of females with the 
average age 53,15 ± 11,4 years. The second group 
included males (average age 49,5 ± 12,2 years). 
NAFLD duration since the disease onset ranged from 
one to fi ve years. The control group consisted of 20 
practically healthy individuals correlative by their age 
and gender to the groups examined. Blood samples 
were obtained in the morning before taking meal from 
antecubital vein until the administration of treatment. 
5% solution of disodium salt of ethylene diamine 
tetraacetate was used as an anticoagulant. The study 
protocol was in accordance with the revised Helsinki 
Declaration (2008) and was approved by the local 
medical ethics committee. Written informed consent 
was obtained from all the participants.
All of the patients and healthy volunteers 
underwent general complex clinical, laboratory and 
instrumental diagnostic investigations. The range of 
indicators of biochemical blood analysis included: total 
bilirubin and its fractions, total protein and albumin, 
urea, creatinine, plasma enzyme activity (aspartate-
aminotransferase (AST), alanineaminotransferase 
(ALT), lactate dehydrogenase (LDH), gamma-
glutamyl transferase (GGT), alkaline phosphatase 
(AP)). 
Lipid profi le investigation included measuring the 
content of cholesterol, triacylglycerols, cholesterol of 
high density lipoproteins (HDL), cholesterol of low 
density lipoproteins (LDL), cholesterol of very low 
density lipoproteins (VLDL) in plasma. For each 
patient or practically healthy individual atherogenic 
index was calculated. Biochemical studies were 
performed on the blood biochemical analyzer 
«Accent-200» («Cormay SA», Poland). 
Key processes of free radical oxidation were 
determined by means of spectrophotometric method 
containing reactive products of tiobarbituric acid 
(TBA-reactive products) in the blood. Antioxidant 
systems were studied by measuring content of reduced 
glutathione, activities of catalase, glutathione-S-
transferase (GST) and glutathione peroxidase (GP).
Statistical processing of the data was performed 
by the computer program PAST Version 2.05 [7]. To 
determine the type of data distribution, comparing 
the arithmetic mean, median and mode, Wilcoxon-
Shapiro test was used. To determine statistical 
differences between two independent groups Mann-
Whitney test was applied.
Results and their discussion. Male patients with 
NAFLD have a signifi cantly higher direct bilirubin 
plasma level, which by 30,0% (p = 0,01) prevailed 
the appropriate level in females (tab. 1). But neither 
in males nor in females it wasn’t higher than the 
parameters of common normal values. Males also 
showed evaluated creatinine plasma concentration, 
which was by 13,0% (p < 0,0001) higher as compared 
with female patients.
For the patients of the second group increased 
activity of transaminases as compared with patients of 
the fi rst group was typical. In particular, in males AST 
increased by 45,4% (p = 0,0003) and ALT – by 57,0% 
(p < 0,0001) respectively as compared with females 
(tab. 1). Our results are coinside with the data of other 
investigators [10], which revealed that male gender 
is associated with increased aminotransferase activity 
and more frequent development of liver fi brosis. 
Moreover, increased GGT activity was inherent 
for the observed male patients with NAFLD. Activity 
of this enzyme in patients of the second group was 
more than twice higher (p < 0,0001) as compared 
with the appropriate parameters in patients of the 
fi rst group (tab. 1). GGT plays an important role 
in metabolism of aminoacids and is a marker of 
intoxication, including dysmetabolic one. Also, GGT 
is believed to bind molecules of substances that 
should be excreated, thus increasing of its activity 
may be indicative of augmentation of toxical load 
and serve as an indicator of increased cholestasis [2]. 
That’s why we can conclude, that increased activity of 
GGT in male patients with NAFLD probably refl ect 
augmented intoxication syndrome as compared with 
female patients.
Male patients with NAFLD were characterized 
by signifi cantly lower at 10,6% (p=0,03) general 
cholesterol plasma level as compared with females 
(tab. 2). 
That was accompanied by decreased plasma 
concentration of cholesterol of HDL and LDL by 
17,7% (p = 0,001) and by 15,4% (p = 0,05) respectively, 
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Table 1 




n = 20 
Patients with NAFLD, n = 139
Females, 
n = 68 Males, n = 71
Glucose, mmol/L (N= 3,9-6,0 mmol/L) 4,8 ± 0,19 6,5 ± 0,27p1 < 0,0001
6,5 ± 0,35
p1 < 0,0001
Total bilirubin, mkmol/L (N=5,0-20,5) 10,3 ± 0,76 11,8 ± 0,70 13,3 ± 0,81
Direct bilirubin, mkmol/L 
(N=0,5-5,0) 2,6 ± 0,29 3,0 ± 0,34
3,9 ± 0,36
p1 = 0,03, 
p2 = 0,01
Albumin, g/L (N=35-50) 46,3 ± 0,53 44,0 ± 0,40p1 = 0,002
45,4 ± 0,62
Total protein, g/L (N=65-85) 70,8 ± 0,93 71,0 ± 0,64 72,6 ± 0,77p2 = 0,05
Urea, mmol/L (N=2,4-8,3) 4,3 ± 0,39 5,4 ± 0,32 5,3 ± 0,26p1 = 0,04
Creatinine, mkmol/L (N=40-110) 80,6 ± 2,99 82,1 ± 1,92
92,8 ± 2,67
p1 = 0,005, 
p2 < 0,0001
Aspartate aminotransferase, units of action/L 
(N<37) 24,9 ± 2,50 24,0 ± 1,38
34,9 ± 2,48
p1 = 0,05, 
p2 = 0,0003




Lactate dehydrogenase, units of action/L (N=210-





Alkaline phosphatase, units of action/L (N=42-141) 84,7 ± 5,40 90,9 ± 2,64p1 = 0,04
88,6 ± 3,53
Gamma-glutamyl transferase, units of action/L 












Patients with NAFLD, n = 139
Females, 
n = 68 Males, n = 71
Cholesterol, mmol/l 4,72 ± 0,24 5,95 ± 0,18p1 = 0,0005
5,38 ± 0,18
p1 = 0,02, p2 = 0,03
Triacylglycerols, mmol/l 1,26 ± 0,13 1,94 ± 0,10p1 = 0,0001
2,17 ± 0,18
p1 = 0,001
Cholesterol HDL, mmol/l 1,50 ± 0,06 1,46 ± 0,04 1,24 ± 0,04p1 = 0,001, p2 < 0,0001
Cholesterol LDL, mmol/l 3,03 ± 0,23 3,60 ± 0,16p1 = 0,03
3,12 ± 0,15
p2 = 0,05
Cholesterol VLDL, mmol/l 0,62 ± 0,07 0,89 ± 0,05p1 = 0,008
1,02 ± 0,09
p1 = 0,02
Atherogenic index 2,44 ± 0,21 3,15 ± 0,12p1 = 0,01
3,41 ±  0,13
p1 = 0,002
p1 – signifi cance of differences compared with the indicators in the group of healthy people; p2 – signifi cance of differences 
compared with rates in NAFLD patients of female gender. 
p1 – signifi cance of differences compared with the indicators in the group of healthy people; p2 – signifi cance of differences 
compared with rates in NAFLD patients of female gender. 
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as compared with female patients. Atherogenic index 
was higher in patients of both groups as compared 
with healthy volunteers. In patients of the fi rst group 
this indicator was higher by 29,1% (p = 0,01) and in 
patients of the second group – by 39,8% (p = 0,002) 
in comparison with the appropriate control parameter. 
Signifi cant differences in atherogenic index between 
patients of both studied groups were not found.
Increased contents of glutathione peroxidase and 
glutathione-S-transferase activity, elevated TBA-
reactive products in plasma, decreased level of 
reduced glutathione in the blood of NAFLD patients 
of both studied groups, in comparison with similar 
indicators in practically healthy individuals were 
detected (tab. 3). 
In female patients with NAFLD a signifi cant 
decrease of catalase plasma activity was observed, 
male patients showed a tendency to such 
decreasement. No signifi cant differences between 
NAFLD patients of different genders in parameters 
of pro- and antioxidant systems were found. 
Conclusions. Male gender among NAFLD 
patients is associated with increased activity of 
aspartateaminotransferase, alanineaminotransferase 
and gamma-glutamyltransferase plasma activities. 
Female patients with NAFLD were characterized 
by signifi cantly higher general cholesterol plasma 
level together with elevated cholesterol of high 
density lipoproteins and low density lipoproteins 
concentrations as compared with males. There were 
no signifi cant differences between NAFLD patients 
of different genders in parameters of pro- and 
antioxidant systems.
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Table 3 
Pro- and antioxidant indicators in patients with nonalcoholic fatty liver disease according to their gender 
Plasma level Healthy volunteers,n = 20
Patients with NAFLD, n = 139
Females, 
n = 68 Males, n = 71
Reduced glutathione,  mmol/l 1,15 ± 0,04 0,81 ± 0,03p1 < 0,0001
0,84 ± 0,04
p1 < 0,0001
Glutathione peroxidase, nmol/min*mg of 











Catalase, mkmol/min*l 15,02 ± 0,89 12,21± 0,43p1 = 0,04
12,89 ± 0,86
Reactive products of tiobarbituric acid, 





p1 – signifi cance of differences compared with the indicators in the group of healthy people; p2 – signifi cance of differences 
compared with rates in NAFLD patients of female gender.
